NCT01010997

Foresee Home for Monitoring Age Related Macular Degeneration (AMD)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 10 (actual)
• Sponsor: Notal Vision Ltd. · Industry
• Sex: All
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

The FORESEE HOME is intended for the early detection of central and paracentral irregularities (abnormalities) in the visual field, most commonly associated with AMD. However, the device has ability to detect the development of the lesion post treatment and therefore to asses in determination of the next treatment.

Detailed description

The FORESEE HOME is intended for the early detection of central and paracentral irregularities (abnormalities) in the visual field, most commonly associated with AMD. However, the device has ability to detect the development of the lesion post treatment and therefore to asses in determination of the next treatment. The OCT May be use as well to identify choroidal neovascularization (CNV). Comparison between the two methods will allow better understanding of both devices. The FORESEE HOME can use as an assessment tool for the progression and success of the treatment given to AMD lesions. Therefore, evaluation the size and the location of the treated lesions may serve as an additional tool.

Conditions

• Age Related Macular Degeneration

Interventions

Type	Name	Description
DEVICE	Foresee Home	using the Foresee home device

Timeline

• Start date: 2009-12-01
• Primary completion: 2012-01-01
• Completion: 2012-01-01
• First posted: 2009-11-10
• Last updated: 2012-07-31

Locations

1 site across 1 country: Israel